Biliary Involvement in Type 2 Autoimmune Pancreatitis

Autoimmune pancreatitis (AIP) is a rare condition classified in 2 subtypes. Their distinction relies on a combination of clinical, serological, morphological and histological features. Type 1 is a pancreatic manifestation of IgG4-related disease characterized by multiorgan infiltration by IgG4 plasm...

Full description

Bibliographic Details
Main Authors: Diana Ollo, Sylvain Terraz, Gregoire Arnoux, Giacomo Puppa, Jean-Louis Frossard, Philippe Bichard
Format: Article
Language:English
Published: Karger Publishers 2019-04-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:https://www.karger.com/Article/FullText/499422
_version_ 1828802265927909376
author Diana Ollo
Sylvain Terraz
Gregoire Arnoux
Giacomo Puppa
Jean-Louis Frossard
Philippe Bichard
author_facet Diana Ollo
Sylvain Terraz
Gregoire Arnoux
Giacomo Puppa
Jean-Louis Frossard
Philippe Bichard
author_sort Diana Ollo
collection DOAJ
description Autoimmune pancreatitis (AIP) is a rare condition classified in 2 subtypes. Their distinction relies on a combination of clinical, serological, morphological and histological features. Type 1 is a pancreatic manifestation of IgG4-related disease characterized by multiorgan infiltration by IgG4 plasmocytes. In this condition, hepatobiliary infiltration is frequent and often mimics cholangiocarcinoma or primary sclerosing cholangitis. On the other hand, type 2 is commonly limited to the pancreas. Herein, we describe the case of a patient who presented a type 2 AIP associated with cholangiopathy, a condition not described in the established criteria. He first developed a pancreatitis identified as type 2 by the typical histopathological features and lack of IgG4 in the serum and tissue. Despite a good clinical response to steroids, cholestasis persisted, identified by MR cholangiography as a stricture of the left hepatic duct with dilatation of the intrahepatic bile duct in segments 2 and 3. Biliary cytology was negative. Evolution was favorable but after steroid tapering a few months later, the patient suffered from recurrence of the pancreatitis as well as progression of biliary attempt, suspicious for cholangiocarcinoma. As the investigations again ruled out neoplastic infiltration or primary sclerosing cholangitis, azathioprine was initiated with resolution of both pancreatic and biliary attempts.
first_indexed 2024-12-12T07:01:01Z
format Article
id doaj.art-c205bf4242dc4645bd2cf9e5775fcdaa
institution Directory Open Access Journal
issn 1662-0631
language English
last_indexed 2024-12-12T07:01:01Z
publishDate 2019-04-01
publisher Karger Publishers
record_format Article
series Case Reports in Gastroenterology
spelling doaj.art-c205bf4242dc4645bd2cf9e5775fcdaa2022-12-22T00:33:51ZengKarger PublishersCase Reports in Gastroenterology1662-06312019-04-0113120020610.1159/000499422499422Biliary Involvement in Type 2 Autoimmune PancreatitisDiana OlloSylvain TerrazGregoire ArnouxGiacomo PuppaJean-Louis FrossardPhilippe BichardAutoimmune pancreatitis (AIP) is a rare condition classified in 2 subtypes. Their distinction relies on a combination of clinical, serological, morphological and histological features. Type 1 is a pancreatic manifestation of IgG4-related disease characterized by multiorgan infiltration by IgG4 plasmocytes. In this condition, hepatobiliary infiltration is frequent and often mimics cholangiocarcinoma or primary sclerosing cholangitis. On the other hand, type 2 is commonly limited to the pancreas. Herein, we describe the case of a patient who presented a type 2 AIP associated with cholangiopathy, a condition not described in the established criteria. He first developed a pancreatitis identified as type 2 by the typical histopathological features and lack of IgG4 in the serum and tissue. Despite a good clinical response to steroids, cholestasis persisted, identified by MR cholangiography as a stricture of the left hepatic duct with dilatation of the intrahepatic bile duct in segments 2 and 3. Biliary cytology was negative. Evolution was favorable but after steroid tapering a few months later, the patient suffered from recurrence of the pancreatitis as well as progression of biliary attempt, suspicious for cholangiocarcinoma. As the investigations again ruled out neoplastic infiltration or primary sclerosing cholangitis, azathioprine was initiated with resolution of both pancreatic and biliary attempts.https://www.karger.com/Article/FullText/499422Biliary involvementAutoimmune pancreatitis
spellingShingle Diana Ollo
Sylvain Terraz
Gregoire Arnoux
Giacomo Puppa
Jean-Louis Frossard
Philippe Bichard
Biliary Involvement in Type 2 Autoimmune Pancreatitis
Case Reports in Gastroenterology
Biliary involvement
Autoimmune pancreatitis
title Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_full Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_fullStr Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_full_unstemmed Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_short Biliary Involvement in Type 2 Autoimmune Pancreatitis
title_sort biliary involvement in type 2 autoimmune pancreatitis
topic Biliary involvement
Autoimmune pancreatitis
url https://www.karger.com/Article/FullText/499422
work_keys_str_mv AT dianaollo biliaryinvolvementintype2autoimmunepancreatitis
AT sylvainterraz biliaryinvolvementintype2autoimmunepancreatitis
AT gregoirearnoux biliaryinvolvementintype2autoimmunepancreatitis
AT giacomopuppa biliaryinvolvementintype2autoimmunepancreatitis
AT jeanlouisfrossard biliaryinvolvementintype2autoimmunepancreatitis
AT philippebichard biliaryinvolvementintype2autoimmunepancreatitis